Windtree Therapeutics, Inc.2024财年第三财季实现净利润-2.75百万美元，同比增加37.92%

市场透视11-28

11月28日，Windtree Therapeutics, Inc.（WINT.US）公布财报，公告显示公司2024财年第三财季净利润为-2.75百万美元，同比增加37.92%；其中营业收入为0.00美元，每股基本收益为-4.23美元。从资产负债表来看，Windtree Therapeutics, Inc.（WINT.US）总负债23.90百万美元，其中短期债务10.20百万美元，资产负债比为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2486394183?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-28 10:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2486394183","market":"us","top_or_hot":-1,"title":"Windtree Therapeutics, Inc.2024财年第三财季实现净利润-2.75百万美元，同比增加37.92%","media":"市场透视","content":"<div>\n<p>11月28日，Windtree Therapeutics, Inc.（WINT.US）公布财报，公告显示公司2024财年第三财季净利润为-2.75百万美元，同比增加37.92%；其中营业收入为0.00美元，每股基本收益为-4.23美元。从资产负债表来看，Windtree Therapeutics, Inc.（WINT.US）总负债23.90百万美元，其中短期债务10.20百万美元，资产负债比为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128100131abe49bb4&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Windtree Therapeutics, Inc.2024财年第三财季实现净利润-2.75百万美元，同比增加37.92%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWindtree Therapeutics, Inc.2024财年第三财季实现净利润-2.75百万美元，同比增加37.92%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-28 10:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128100131abe49bb4&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月28日，Windtree Therapeutics, Inc.（WINT.US）公布财报，公告显示公司2024财年第三财季净利润为-2.75百万美元，同比增加37.92%；其中营业收入为0.00美元，每股基本收益为-4.23美元。从资产负债表来看，Windtree Therapeutics, Inc.（WINT.US）总负债23.90百万美元，其中短期债务10.20百万美元，资产负债比为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128100131abe49bb4&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WINTW","symbol_name":"Windtree Therapeutics, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128100131abe49bb4&s=b","article_id":"2486394183","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128100131abe49bb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2486394183","pubTimestamp":1732759282,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月28日，Windtree Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-2.75百万美元，同比增加37.92%；其中营业收入为0.00美元，每股基本收益为-4.23美元。从资产负债表来看，Windtree Therapeutics, Inc.总负债23.90百万美元，其中短期债务10.20百万美元，资产负债比为1.28，流动比率为0.28。机构评级：截至2024年11月28日，当前有1家机构对Windtree Therapeutics, Inc.目标价做出预测，其中目标均价为18.00美元，其中最低目标价为18.00美元，最高目标价为18.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"WINTW":"Windtree Therapeutics, Inc.","WINT":"Windtree Therapeutics, Inc.","LENZ":"Therapeutics"},"translate_title":"Windtree Therapeutics, Inc. achieved net profit of-US $2.75 million in the third fiscal quarter of fiscal year 2024, a year-on-year increase of 37.92%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"WINT":1,"WINTW":1},"content_text":"11月28日，Windtree Therapeutics, Inc.（WINT.US）公布财报，公告显示公司2024财年第三财季净利润为-2.75百万美元，同比增加37.92%；其中营业收入为0.00美元，每股基本收益为-4.23美元。从资产负债表来看，Windtree Therapeutics, Inc.（WINT.US）总负债23.90百万美元，其中短期债务10.20百万美元，资产负债比为1.28，流动比率为0.28。机构评级：截至2024年11月28日，当前有1家机构对Windtree Therapeutics, Inc.目标价做出预测，其中目标均价为18.00美元，其中最低目标价为18.00美元，最高目标价为18.00美元。公司简介：Windtree Therapeutics Inc是一家处于开发阶段的生物技术公司，专注于开发用于呼吸系统疾病的KL4表面活性剂疗法。该公司的技术平台包括合成的含肽表面活性剂和新型的药物输送技术，这些技术可以在没有侵入性操作的情况下输送雾化的KL4表面活性剂。其开发项目利用其专有技术平台是AEROSURF，用于治疗早产儿呼吸窘迫综合征。它的业务领域是专注于表面活性剂治疗呼吸系统疾病的产品研发，以及经批准产品的制造和商业销售。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486394183"}